Gene · 1300
Papers2,140
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,140
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| COL10A1 overexpression potentially contributes to poor outcomes in breast cancer via autophagy and vasculogenic mimicry. | Transl Cancer Res | 2026 | 42305518 | PubTator, text mining | PubMed |
| FGF19 promotes cartilage destruction in the progress of temporomandibular joint osteoarthritis. | Cell Tissue Res | 2026 | 42247043 | PubTator, text mining | PubMed |
| Circulating biomarker profile and its diagnostic predictive utility in age-related macular degeneration. | Biomark Med | 2026 | 42233695 | PubTator, text mining | PubMed |
| Fibroblast Growth Factor 2-Immobilized Biointerfaces Drive Exogenous Transforming Growth Factor β1-Independent Chondrogenesis of Human Mesenchymal Stem Cell and Ectopic Cartilage Tissue Formation. | Biomater Res | 2026 | 42232853 | PubTator, text mining | PubMed |
| Vasoactive intestinal peptide advances chondrogenesis and modulates pathogenic mediators in human osteoarthritis. | J Mol Med (Berl) | 2026 | 42178419 | PubTator, text mining | PubMed |
| COL10A1 beyond skeletal development: a hypertrophic chondrocyte-specific collagen emerging as a potential biomarker and tumor microenvironment regulator in solid cancers. | Am J Cancer Res | 2026 | 42163866 | PubTator, text mining | PubMed |
| Media matters: phenol red and fetal bovine serum estrogen in traditional cell culture media influence human mesenchymal stromal cell (hMSC) processes and differentiation in a sex-biased manner. | Biol Sex Differ | 2026 | 42157281 | PubTator, text mining | PubMed |
| Evaluation of Colombian silk fibroin hydrogels functionalized with recombinant LSECtin for intervertebral disc tissue engineering. | PLoS One | 2026 | 42139309 | PubTator, text mining | PubMed |
| FMO1 disrupts mitochondrial functional homeostasis through ROS-mediated mechanisms to drive chondrocyte senescence and hypertrophy. | Free Radic Biol Med | 2026 | 42105790 | PubTator, text mining | PubMed |
| Chondrogenic differentiation of human periosteum-derived cells in spheroids, HAMA hydrogels, and bioprinted constructs: comparison of kartogenin and TGF-β1. | Biomed Mater | 2026 | 42102888 | PubTator, text mining | PubMed |
| FGF8 accelerates osteoarthritic chondrocyte hypertrophy by JunB-mediated cytokine perturbation. | Life Sci | 2026 | 41990914 | PubTator, text mining | PubMed |
| A Conserved Fibroblast-Myeloid Gene Signature in Digestive Cancers: Multi-Omics Integration Identifies DCN, COL10A1, CTHRC1, and TREM2 as Candidate Microenvironmental Markers. | Int J Mol Sci | 2026 | 41977392 | PubTator, text mining | PubMed |
| Age-associated regulation of chondrocyte hypertrophy in osteoarthritis: Mechanisms, therapeutic implications, and cartilage fate reprogramming. | Ageing Res Rev | 2026 | 41967814 | PubTator, text mining | PubMed |
| Overexpression of COL10A1 in extracellular matrix predicts poor outcome and promotes ovarian cancer progression. | BMC Cancer | 2026 | 41963830 | PubTator, text mining | PubMed |
| Comparative Effects of Dexamethasone and ASC Secretome in an Ex Vivo Osteoarthritis Co-Culture Model. | Biology (Basel) | 2026 | 41892253 | PubTator, text mining | PubMed |
| Retraction: miR-384 induces apoptosis and autophagy of non-small cell lung cancer (NSCLC) cells through the negative regulation of Collagen alpha-1(X) chain (COL10A1) gene. | Biosci Rep | 2026 | 41883266 | PubTator, text mining | PubMed |
| Targeting EFEMP1 enhances chondrogenesis and inhibits hypertrophic differentiation in a spontaneous osteoarthritis mouse model. | J Mol Med (Berl) | 2026 | 41848842 | PubTator, text mining | PubMed |
| Pathology-guided design of injectable hydrogels for precision therapy and cartilage regeneration in osteoarthritis. | Regen Biomater | 2026 | 41797965 | PubTator, text mining | PubMed |
| Endogenous retroviral elements LTR8B and MER65 rewire PSG9 regulation to control trophoblast syncytialization and pre-eclampsia risk. | Genome Biol | 2026 | 41796334 | PubTator, text mining | PubMed |
| Transcriptomics in Venous Leg Ulcers (VLU): A Systematic Review. | Wound Repair Regen | 2026 | 41787822 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1300/papers?page=2